Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2023-07-27 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-23-043519 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-27 | 2023-07-25 | ALXO | GARCIA PETER S | CFO | A - Grant | $0.00 | +32.0K | 86.7K | +58% | $0 |
| D | 2023-07-27 | 2023-07-25 | ALXO | GARCIA PETER S | CFO | A - Grant | $0.00 | +101.0K | 101.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-25 | A | A | 32,000 | $0.00 | 86,738 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-07-25 | A | A | 101,000 | $0.00 | 101,000 | D | $5.86 · — to 2033-07-24 | 101,000 Common Stock | (F2) Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. |